Revision of Definition of Compendia as Authoritative Source for Use in the Determination of a MedicallyAccepted Indication of Drugs/Biologicals Used Offlabel in AntiCancer Chemothe


Date Issued: 01-29-2010
Implementation Date: 03-01-2010
Effective Date: 01-01-2010
Source: CMS - Transmittal
Source#: CR6806
Category: Cov/Bund Drugs
CBSI Contact: Missy Tieken
 
Effective January 1, 2010, pursuant to section 182(b) of MIPPA, CMS is making corresponding revisions in Pub. 10002, Medicare Benefit Policy Manual, chapter 15, section 50.4.5, for use in the determination of a medicallyaccepted indication of drugs and biologicals used offlabel in an anticancer chemotherapeutic regimen.

http://www.cms.gov/transmittals/downloads/R120BP.pdf



<< Return to News